First 515 words of the document:
Issue date: February 2006 NHS
Review date: September 2008
National Institute for
Health and Clinical Excellence
Quick reference guide
Computerised cognitive behaviour therapy for
depression and anxiety (review)
NOTE: This guidance replaces Technology Appraisal Guidance No. 51 issued in October 2002.
The Institute reviews each piece of guidance it issues.
The review and re-appraisal of the use of computerised cognitive behaviour therapy (CCBT) for depression and anxiety
has resulted in a change in the guidance. In 2002, CCBT was not recommended. In this new guidance two CCBT
packages have been recommended: Beating the Blues for the management of mild and moderate depression and
FearFighter for the management of panic and phobia.
1 Guidance 1.3 FearFighter is recommended as an option for
delivering CBT in the management of panic and
This review concerns five specific packages for the
delivery of computerised cognitive behaviour
therapy (CCBT) accessed via a referral from a 1.4 OCFighter (previously known as BTSteps) is not
general practitioner (GP): three for depression recommended as an option for delivering CBT in
(Beating the Blues, COPE and Overcoming the management of OCD.
Depression), one for panic/phobia (FearFighter) and 1.5 People currently using OCFighter, whether as
one for obsessive-compulsive disorder (OCD) routine therapy or as part of a clinical trial, should
(OCFighter, previously known as BTSteps). have the option to continue on therapy until the
This guidance should be read in the context of the person, or the GP and/or specialist, consider it
clinical guidelines on depression, anxiety and OCD. appropriate to stop.
1.1 Beating the Blues is recommended as an
option for delivering cognitive behaviour This appraisal is supported by the following
therapy (CBT) in the management of mild implementation tools available on our website
and moderate depression. (www.nice.org.uk/TA097):
1.2 There is insufficient evidence to · a national costing report, which estimates the
recommend the use of COPE and overall resource impact associated with
Overcoming Depression as a clinically or implementation
cost-effective option for the management · a local costing template: a simple spreadsheet
of depression, except as part of ongoing or that can be used to estimate the local cost of
new clinical trials that are designed to implementation.
generate robust and relevant data on the
Suggestions for audit to measure compliance
clinical effectiveness of these specific CCBT
locally can be found in the full guidance (see
Technology Appraisal Guidance 97
This guidance is written in the following context
This guidance represents the view of the Institute, which was arrived at after careful consideration of the available
evidence. Healthcare professionals are expected to take it fully into account when exercising their clinical
judgement. This guidance does not, however, override the individual responsibility of healthcare professionals to
make appropriate decisions in the circumstances of the individual patient, in consultation with the patient and/or
guardian or carer.
Other pages in this set
Here's a taster:
Further information Related guidance
Quick reference guide For information about NICE guidance that has been issued
or is in development, see the website (www.nice.org.uk).
This has been distributed to healthcare professionals
working in the NHS in England and Wales Depression: management of depression in primary and
(see www.nice.org.uk/TA097distributionlist). It is available secondary care. NICE Clinical Guideline No. 23 (2004).
from www.nice.org.uk/TA097quickrefguide Available from: www.nice.org.…read more